Neuroleptic Malignant Syndrome: A Case Aimed at Raising Clinical Awareness

Case Reports in Medicine

Volumn 2015, Issue , 2015, Pages

  Al Danaf, Jad ^a   Madara, John ^a   Dietsche, Caitlin ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AZITHROMYCIN; BROMOCRIPTINE; CREATINE KINASE; DANTROLENE; ESCITALOPRAM; FENTANYL; IBUPROFEN; LORAZEPAM; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; RISPERIDONE; VALPROIC ACID; VANCOMYCIN;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG WITHDRAWAL; DYSAUTONOMIA; FEVER; HUMAN; HYPERTHERMIA; HYPOREFLEXIA; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; RIGIDITY; SEPSIS; STREPTOCOCCUS PNEUMONIA;

EID: 85010387291     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2015/769576     Document Type: Article

References (13)

1. R. J. Gurrera, S. N. Caroff, A. Cohen et al., "An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method," The Journal of Clinical Psychiatry, vol. 72, no. 9, pp. 1222-1228, 2011.
2. K. C. Mills, "Serotonin syndrome. A clinical update," Critical Care Clinics, vol. 13, no. 4, pp. 763-783, 1997.
3. J. R. Strawn, P. E. Keck Jr., and S. N. Caroff, "Neuroleptic malignant syndrome," American Journal of Psychiatry, vol. 164, no. 6, pp. 870-876, 2007.
4. S. Waldorf, "Update for nurse anesthetists: neuroleptic malignant syndrome," Journal of the American Association of Nurse Anesthetists, vol. 71, no. 5, pp. 389-394, 2003.
5. V. R. Velamoor, "Neuroleptic malignant syndrome. Recognition, prevention and management," Drug Safety, vol. 19, no. 1, pp. 73-82, 1998.
6. E.W. Boyer and M. Shannon, "Current concepts: the serotonin syndrome," The New England Journal of Medicine, vol. 352, no. 11, pp. 1112-1120, 2005.
7. V. R. Velamoor, R. M. G. Norman, S. N. Caroff, S. C. Mann, K. A. Sullivan, and R. E. Antelo, "Progression of symptoms in neuroleptic malignant syndrome," Journal of Nervous and Mental Disease, vol. 182, no. 3, p. 168, 1994.
8. S.N. Caroffand S. C. Mann, "Neurolepticmalignant syndrome," Medical Clinics of North America, vol. 77, no. 1, pp. 185-202, 1993.
9. P. Adnet, P. Lestavel, and R. Krivosic-Horber, "Neuroleptic malignant syndrome," British Journal of Anaesthesia, vol. 85, no. 1, pp. 129-135, 2000.
10. P. Rosebush and T. Stewart, "A prospective analysis of 24 episodes of neurolepticmalignant syndrome," American Journal of Psychiatry, vol. 146, no. 6, pp. 717-725, 1989.
11. M. J. Bhanushali and P. J. Tuite, "The evaluation and management of patients with neuroleptic malignant syndrome," Neurologic Clinics, vol. 22, no. 2, pp. 389-411, 2004.
12. J. M. Davis, P. G. Janicak, P. Sakkas, C. Gilmore, and Z. Wang, "Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome," Convulsive Therapy, vol. 7, no. 2, pp. 111-120, 1991.
13. Ü. Tural and E. Ónder, "Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death," Psychiatry and Clinical Neurosciences, vol. 64, no. 1, pp. 79-87, 2010.